CHORDC2P

Across TCGA pan-cancer cohorts, CHORDC2P RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated CHORDC2P data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher CHORDC2P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CHORDC2P expression acts as an unfavorable survival marker, although some lineages such as LUSC and THYM show a favorable association.

COAD, KIRC, and BLCA are the cancer types where CHORDC2P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Quartile	IV	0.253	0.537	.002	39	view →
KIRC	DFS	Median	All	0.742	0.840	.019	34	view →
BLCA	DFS	Tertile	II,III,IV	0.419	0.580	.002	29	view →
LUSC	OS	Quartile	All	0.876	0.703	.003	26	view →
MESO	OS	Tertile	IV	0.077	0.638	<.001	18	view →
LGG	DFS	Quartile	All	0.378	0.596	.004	13	view →
THYM	OS	Median	II,III,IV	0.952	0.747	.013	11	view →
LIHC	OS	Tertile	All	0.693	0.820	.009	8	view →
LUAD	DFS	Tertile	III,IV	0.351	0.546	.018	8	view →
READ	DFS	Tertile	III,IV	0.618	0.209	.031	6	view →
KICH	DFS	Quartile	II,III,IV	0.624	0.936	.048	4	view →
CESC	DFS	Median	II,III,IV	0.301	0.677	.030	4	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

CHORDC2P–COAD (DFS)

Open the COAD breakdown →